OUR MISSION

NeuroScios GmbH –  NEUROSCIENCE OPTIMIZED SOLUTIONS

30 years of experience in CNS drug development – the fastest track from molecule to clinic

  • Support the development of new treatments for CNS diseases

    • Alzheimer’s disease

    • Parkinson’s disease

    • Orphan neurodegenerative disorders

    • Cerebrovascular diseases

    • Psychiatric diseases

  • Accelerate the drug/ treatment development by our profound knowledge of the requirements

    • Pharmacology

    • ADME

    • Toxicology

    • Regulatory issues (IND/ CTA)

    • Clinical trials

  • Optimize the chance of success, by knowing

    • The most suitable preclinical models

    • The most experienced and reliable service providers

    •  The competitive environment

  • Support our clients in the best way by

    • Designing most efficient individualized development plan

    • Providing an outstanding network of KOLs in different fields of CNS diseases

    • Fastest reaction time  

    • Competitive pricing

    • International experience for more than 30 years

WHAT MAKES US DIFFERENT?

OUR SERVICE IS EXPERTISE – WE ARE DEDICATED TO YOUR SUCCESS

  • Profound scientific background

    • We understand drug targets and mechanisms of action

    • We know about challenges for a CNS compound

    • We have experience in translational research

  • Years of experience in academia, pharmaceutical and CRO industry

  • Practical experience with

    • Neuronal tissue culture

    • Induced  and transgenic disease models

    • Drug metabolism and Pharmacokinetics

    • Safety pharmacology and toxicology

    • Clinical trials – Biomarkers –Imaging- Neuropsychological testing

WE KNOW WHAT YOU NEED – BECAUSE WE DID IT ALREADY – MORE THAN ONCE

 

 

 

AD/PD Meeting 2020

The AAT-AD/PD™ Focus Meeting 2020 held online this year will present all the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical trials in Alzheimer’s, Parkinson’s and other related neurological disorders.